382 related articles for article (PubMed ID: 29182455)
1. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system.
Thom G; Hatcher J; Hearn A; Paterson J; Rodrigo N; Beljean A; Gurrell I; Webster C
MAbs; 2018; 10(2):304-314. PubMed ID: 29182455
[TBL] [Abstract][Full Text] [Related]
2. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
Webster CI; Caram-Salas N; Haqqani AS; Thom G; Brown L; Rennie K; Yogi A; Costain W; Brunette E; Stanimirovic DB
FASEB J; 2016 May; 30(5):1927-40. PubMed ID: 26839377
[TBL] [Abstract][Full Text] [Related]
3. A novel platform for engineering blood-brain barrier-crossing bispecific biologics.
Farrington GK; Caram-Salas N; Haqqani AS; Brunette E; Eldredge J; Pepinsky B; Antognetti G; Baumann E; Ding W; Garber E; Jiang S; Delaney C; Boileau E; Sisk WP; Stanimirovic DB
FASEB J; 2014 Nov; 28(11):4764-78. PubMed ID: 25070367
[TBL] [Abstract][Full Text] [Related]
4. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.
Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV
FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1.
Stocki P; Szary J; Rasmussen CLM; Demydchuk M; Northall L; Logan DB; Gauhar A; Thei L; Moos T; Walsh FS; Rutkowski JL
FASEB J; 2021 Feb; 35(2):e21172. PubMed ID: 33241587
[TBL] [Abstract][Full Text] [Related]
6. Identifying blood-brain-barrier selective single-chain antibody fragments.
Jones AR; Stutz CC; Zhou Y; Marks JD; Shusta EV
Biotechnol J; 2014 May; 9(5):664-74. PubMed ID: 24644233
[TBL] [Abstract][Full Text] [Related]
7. Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.
Karaoglu Hanzatian D; Schwartz A; Gizatullin F; Erickson J; Deng K; Villanueva R; Stedman C; Harris C; Ghayur T; Goodearl A
MAbs; 2018 Jul; 10(5):765-777. PubMed ID: 29771629
[TBL] [Abstract][Full Text] [Related]
8. The Metalloprotease, Mpr1, Engages AnnexinA2 to Promote the Transcytosis of Fungal Cells across the Blood-Brain Barrier.
Na Pombejra S; Salemi M; Phinney BS; Gelli A
Front Cell Infect Microbiol; 2017; 7():296. PubMed ID: 28713781
[TBL] [Abstract][Full Text] [Related]
9. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
[TBL] [Abstract][Full Text] [Related]
10. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
[TBL] [Abstract][Full Text] [Related]
11. Mouse embryonic stem cell-derived blood-brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis.
Jezierski A; Huang J; Haqqani AS; Haukenfrers J; Liu Z; Baumann E; Sodja C; Charlebois C; Delaney CE; Star AT; Liu Q; Stanimirovic DB
Fluids Barriers CNS; 2023 May; 20(1):36. PubMed ID: 37237379
[TBL] [Abstract][Full Text] [Related]
12. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
[TBL] [Abstract][Full Text] [Related]
13. Transcytosis at the blood-brain barrier.
Ayloo S; Gu C
Curr Opin Neurobiol; 2019 Aug; 57():32-38. PubMed ID: 30708291
[TBL] [Abstract][Full Text] [Related]
14. The blood-brain barrier transmigrating single domain antibody: mechanisms of transport and antigenic epitopes in human brain endothelial cells.
Abulrob A; Sprong H; Van Bergen en Henegouwen P; Stanimirovic D
J Neurochem; 2005 Nov; 95(4):1201-14. PubMed ID: 16271053
[TBL] [Abstract][Full Text] [Related]
15. Antibody Neutralization of HIV-1 Crossing the Blood-Brain Barrier.
Lorin V; Danckaert A; Porrot F; Schwartz O; Afonso PV; Mouquet H
mBio; 2020 Oct; 11(5):. PubMed ID: 33082263
[TBL] [Abstract][Full Text] [Related]
16. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases.
Zhou X; Smith QR; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Jul; 13(4):e1695. PubMed ID: 33470550
[TBL] [Abstract][Full Text] [Related]
17. Strategies to identify, engineer, and validate antibodies targeting blood-brain barrier receptor-mediated transcytosis systems for CNS drug delivery.
Choi ES; Shusta EV
Expert Opin Drug Deliv; 2023; 20(12):1789-1800. PubMed ID: 38007619
[TBL] [Abstract][Full Text] [Related]
18. Standardized Preclinical
Morrison JI; Petrovic A; Metzendorf NG; Rofo F; Yilmaz CU; Stenler S; Laudon H; Hultqvist G
Mol Pharm; 2023 Mar; 20(3):1564-1576. PubMed ID: 36808999
[TBL] [Abstract][Full Text] [Related]
19. Engineering and pharmacology of blood-brain barrier-permeable bispecific antibodies.
Stanimirovic D; Kemmerich K; Haqqani AS; Farrington GK
Adv Pharmacol; 2014; 71():301-35. PubMed ID: 25307221
[TBL] [Abstract][Full Text] [Related]
20. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
